A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis
- 1 April 2009
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 607 (1-3) , 201-212
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A novel mTOR inhibitor is efficacious in a murine model of colitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Macrophage Migration Inhibitory Factor and Interleukin-8 Produced by Gastric Epithelial Cells during Helicobacter pylori Exposure Induce Expression and Activation of the Epidermal Growth Factor ReceptorInfection and Immunity, 2008
- Alternative Chemical Modifications Reverse the Binding Orientation of a Pharmacophore Scaffold in the Active Site of Macrophage Migration Inhibitory FactorJournal of Biological Chemistry, 2007
- MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitmentNature Medicine, 2007
- Phenolic Hydrazones Are Potent Inhibitors of Macrophage Migration Inhibitory Factor Proinflammatory Activity and Survival Improving Agents in SepsisJournal of Medicinal Chemistry, 2007
- Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activityBioorganic & Medicinal Chemistry Letters, 2006
- ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe SepsisJournal of Biological Chemistry, 2005
- Critical Role of Macrophage Migration Inhibitory Factor Activity in Experimental Autoimmune DiabetesEndocrinology, 2005
- Expression of Macrophage Migration Inhibitory Factor in Different Stages of Human AtherosclerosisCirculation, 2002
- Macrophage migration inhibitory factorCritical Care Medicine, 2002